Skip Navigation


European Heart Journal Advance Access originally published online on November 7, 2006
European Heart Journal 2006 27(24):2969-2974; doi:10.1093/eurheartj/ehl363
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/24/2969    most recent
ehl363v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lenzen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lenzen, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

Mattie Lenzen1, Lars Ryden2, John Öhrvik2, Malgorzata Bartnik2, Klas Malmberg2, Wilma Scholte op Reimer1, Maarten L. Simoons1,* on behalf of the Euro Heart Survey Investigators

1 Thoraxcenter, Department of Cardiology, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
2 Department of Cardiology, Karolinska University Hospital, Solna, Stockholm, Sweden

Received 24 May 2006; revised 25 September 2006; accepted 19 October 2006; online publish-ahead-of-print 7 November 2006.

* Corresponding author. Tel: +31 10 463 3938. E-mail address: m.simoons{at}erasmusmc.nl

Aims Although diabetes is known to be a major contributor to cardiovascular diseases, as well as an independent predictor for adverse outcomes in patients with coronary artery disease (CAD), information on the prognosis of patients with CAD and newly diagnosed diabetes or impaired glucose regulation (IGR) is scarce. The objective of this study was to explore 1-year outcome in relation to different glucometabolic states of patients participating in the Euro Heart Survey on diabetes and the heart.

Methods and results In 4676 out of 4961 patients, information on the relation between 1-year outcome and glucometabolic state, which was based on oral glucose tolerance test (OGTT) or fasting glucose plasma, was available. A normal glucose metabolism was identified in 947 patients, IGR (impaired fasting glucose or impaired glucose tolerance) in 1116 patients, and diabetes in 1877 patients of whom 1425 were previously diagnosed and 452 newly diagnosed. In total, 736 patients could not be classified, as no OGTT or fasting plasma glucose was performed. Previously recognized and newly detected diabetes was associated with an increased risk of 1-year mortality when compared with patients with normal glucose regulation [hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.5–3.8 and HR 2.0, 95% CI 1.1–3.6, respectively)]. IGR, however, could not be identified as an independent predictor for 1-year mortality (HR 1.1, 95% CI 0.6–1.9).

Conclusion This study confirmed that patients with CAD and known diabetes are at high risk for mortality and cardiovascular events and demonstrated that patients with newly diagnosed diabetes are at intermediate risk for adverse outcomes. IGR, however, could not be identified as an independent predictor for adverse outcomes during the 1-year follow-up period.

Key Words: Diabetes • Impaired glucose regulation • Coronary artery disease • Euro Heart Survey


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
E. J. Metter, B. G. Windham, M. Maggio, E. M. Simonsick, S. M. Ling, J. M. Egan, and L. Ferrucci
Glucose and Insulin Measurements from the Oral Glucose Tolerance Test and Mortality Prediction
Diabetes Care, May 1, 2008; 31(5): 1026 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Anselmino, J. Ohrvik, K. Malmberg, E. Standl, L. Ryden, and on behalf of the Euro Heart Survey Investigators
Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart
Eur. Heart J., January 2, 2008; 29(2): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Wallander, K. Malmberg, A. Norhammar, L. Ryden, and A. Tenerz
Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction in Clinical Practice: A report on repeated oral glucose tolerance tests from the GAMI Study
Diabetes Care, January 1, 2008; 31(1): 36 - 38.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D. Preiss and N. Sattar
Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence
Heart, December 1, 2007; 93(12): 1493 - 1496.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.